Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 11/2011

01-11-2011 | Letter to the Editor

Reproducibility of results on chronic pain with MC5-A Calmare® device from independent studies

Authors: Marianna Ricci, Sara Pirotti, Emanuela Scarpi, Marco Burgio, Marco Maltoni, Elisabetta Sansoni, Dino Amadori

Published in: Supportive Care in Cancer | Issue 11/2011

Login to get access

Excerpt

Dear Sir, …
Literature
1.
Ricci M, Pirotti S, Scarpi E, Burgio M, Maltoni M, Sansoni E, Amadori D (2011) Managing chronic pain: results from an open-label study using MC5-A Calmare® device. Support Care Canc. doi:10.​1007/​s00520-011-1128-6
2.
Smith T, Coyne P, Parker G, Dodson P, Ramakrishnan V (2010) Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy induced peripheral neuropathy. J Pain Symptom Manage 40:883–891PubMedCrossRef
3.
Marineo G (2003) Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP 4:1–10PubMed
4.
Sabato AF, Marineo G, Gatti A (2005) Scrambler therapy. Minerva Anestesiol 71:479–482PubMed
Metadata
Title
Reproducibility of results on chronic pain with MC5-A Calmare® device from independent studies
Authors
Marianna Ricci
Sara Pirotti
Emanuela Scarpi
Marco Burgio
Marco Maltoni
Elisabetta Sansoni
Dino Amadori
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2011
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1183-z

Other articles of this Issue 11/2011

Supportive Care in Cancer 11/2011 Go to the issue

Original Article

Nutritional status of patients with locally advanced pancreatic cancer: a pilot study

Original Article

Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials

Original Article

Symptoms, psychological distress, and supportive care needs in lung cancer patients

Original Article

A qualitative assessment of the supportive care and resource needs of patients undergoing craniotomy for benign brain tumours

Short Communication

Treatment referral before and after the introduction of the Liverpool Patients Concerns Inventory (PCI) into routine head and neck oncology outpatient clinics

Original Article

Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits